未登录

S

Stéphanie McArdle

Nottingham Trent University

H指数:24

被引数:1,804

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Improving responses to immunotherapy in glioblastoma multiforme

改善多形性胶质母细胞瘤对免疫疗法的反应

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-04-230

OAAI

A Holistic Approach to Hard-to-Treat Cancers: The Future of Immunotherapy for Glioblastoma, Triple Negative Breast Cancer, and Advanced Prostate Cancer

IF3.9

2023-07-253

OAAI

Canonical and truncated transglutaminase-2 regulate mucin-1 expression and androgen independency in prostate cancer cell lines

CELL DEATH & DISEASE

IF9.6

2023-05-097

OAAI

Prostate Cancer: Early Detection and Assessing Clinical Risk Using Deep Machine Learning of High Dimensional Peripheral Blood Flow Cytometric Phenotyping Data

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-12-168

OAAI

Editorial: Frontiers' Research Topic Cancer Vaccines: Time to Think Differently!

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-10-150

OAAI

Helicase antigen (HAGE)-derived vaccines induce immunity to HAGE and ImmunoBody®-HAGE DNA vaccine delays the growth and metastasis of HAGE-expressing tumors in vivo

IMMUNOLOGY AND CELL BIOLOGY

IF3

2021-09-193

OAAI

Synthesis and Functionalisation of Superparamagnetic Nano-Rods towards the Treatment of Glioblastoma Brain Tumours

IF4.3

2021-08-2416

OAAI

A Novel HAGE/WT1-ImmunoBody(R) Vaccine Combination Enhances Anti-Tumour Responses When Compared to Either Vaccine Alone

FRONTIERS IN ONCOLOGY

IF3.3

2021-06-287

OAAI

Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-02-1777

OAAI

Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment

多形性胶质母细胞瘤的免疫逃逸和免疫治疗的适应性

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-10-1572

OAAI

Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data

IF0

2020-07-2814

OA

Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-α

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2020-01-0319

OAAI

Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation

FRONTIERS IN IMMUNOLOGY

IF5.9

2019-01-2525

OAAI

SP1 and RARα regulate AGAP2 expression in cancer

SP1和RARα 调节肿瘤中AGAP2的表达

SCIENTIFIC REPORTS

IF3.9

2019-01-2315

OAAI

Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast Cancer

FRONTIERS IN IMMUNOLOGY

IF5.9

2018-09-1141

OAAI

Novel PAP-derived vaccine for the treatment of advanced prostate cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

2018-03-012

PREAI

HAGE-derived peptide as a vaccine to prevent relapse in TNBC patients: Proof of concepts

EUROPEAN JOURNAL OF CANCER

IF7.1

2018-03-010

PREAI

Immune Landscape of Breast Cancers

IF3.9

2018-02-1199

OAAI

Identify the Presence of Prostate Cancer in Individuals with PSA Levels <20 ng ml-1 Using Computational Data Extraction Analysis of High Dimensional Peripheral Blood Flow Cytometric Phenotyping Data

FRONTIERS IN IMMUNOLOGY

IF5.9

2017-12-187

OAAI

HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis

CLINICAL CANCER RESEARCH

IF10.2

2016-02-1417

OAAI